Ecolab (ECL)
(Delayed Data from NYSE)
$247.23 USD
+1.00 (0.41%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $247.10 -0.13 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$247.23 USD
+1.00 (0.41%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $247.10 -0.13 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum C VGM
Zacks News
Can Global Industrial Unit Drive Ecolab's (ECL) Q1 Earnings?
by Zacks Equity Research
Ecolab's (ECL) Global Industrial segment is likely to have gained from the Water, Food & Beverage and Life Sciences sub-units in the first quarter.
Why Is Ecolab (ECL) Down 25.6% Since Last Earnings Report?
by Zacks Equity Research
Ecolab (ECL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Coronavirus to Weigh on These 4 Medical Stocks' Q1 Show
by Sreyoshi Mukherjee
The coronavirus pandemic likely to disrupt the first-quarter performances of players in the MedTech space.
Coronavirus, Tariffs Mar Chemical Specialty Industry Outlook
by Anindya Barman
Weak demand and raw material supply disruptions due to coronavirus as well as hefty trade tariffs pose as headwinds to the chemical specialty industry.
Coronavirus-Affected MedTech Drags S&P 500 Index Down
by Trina Mukherjee
Amid uncertainty surrounding the coronavirus outbreak, here are a few S&P 500 MedTech stocks that took a hit.
Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?
by Sweta Killa
Sector ETF report for FMAT
Ecolab (ECL) Earnings and Revenues Miss Estimates in Q4
by Zacks Equity Research
Strength in the Global Industrial arm drives Ecolab's (ECL) Q4 results.
Global Industrial Unit to Drive Ecolab's (ECL) Q4 Earnings
by Zacks Equity Research
Ecolab's (ECL) Q4 results are likely to reflect strength in core Global Industrial unit.
Ecolab's Eco-Flex Teat Dip to Boost Food & Beverage Segment
by Zacks Equity Research
The Eco-Flex Teat Dip launch is likely to expand Ecolab's (ECL) Food & Beverage product portfolio.
Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?
by Zacks Equity Research
Sector ETF report for FMAT
Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?
by Sweta Killa
Sector ETF report for FMAT
Here's Why You Should Hold on to Ecolab (ECL) Stock for Now
by Zacks Equity Research
Ecolab (ECL) slashes 2019 EPS view owing to foreign exchange headwinds.
Ecolab (ECL) Down 3.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ecolab (ECL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Near-Term Prospects Gloomy for Specialty Chemical Stocks
by Anindya Barman
Trade tariffs and raw material cost inflation pose as headwinds to the chemical specialty industry.
Ecolab (ECL) Earnings and Revenues Miss Estimates in Q3
by Zacks Equity Research
Global Industrial unit aid Ecolab's (ECL) Q3 results; 2019 EPS view slashed.
Ecolab (ECL) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Ecolab (ECL) delivered earnings and revenue surprises of -0.58% and -1.77%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Can Global Industrial Unit Drive Ecolab's (ECL) Q3 Earnings?
by Zacks Equity Research
Positive developments in the Global Industrial unit are expected to have driven Ecolab's (ECL) Q3 results.
Here's Why You Should Retain Ecolab (ECL) Stock For Now
by Zacks Equity Research
Ecolab (ECL) continues to gain from robust product portfolio and strong international presence. However, forex remains a woe.
PQG or ECL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PQG vs. ECL: Which Stock Is the Better Value Option?
Ecolab's (ECL) Gallay Medical Buyout to Boost Healthcare Arm
by Zacks Equity Research
The addition of Gallay Medical is likely to boost Ecolab's (ECL) Healthcare offerings.
Cintas (CTAS) Shares Rises 49% YTD: What's Driving the Rally?
by Zacks Equity Research
Cintas (CTAS) rises year to date, outperforming the industry, the sector and the S&P 500. Solid product portfolio, acquired assets, shareholder-friendly policies and outlook are few driving factors.
Should You Invest in the Fidelity MSCI Materials Index ETF (FMAT)?
by Zacks Equity Research
Sector ETF report for FMAT
Ecolab's (ECL) Nalco Water Opens Customer Experience Center
by Zacks Equity Research
Ecolab (ECL) expects Nalco's water technologies to reduce freshwater usage by 20%.
Here's Why You Should Hold on to Ecolab (ECL) Stock Now
by Zacks Equity Research
Ecolab (ECL) continues to gain from robust product portfolio and strong international presence. However, forex remains a woe.
Ecolab (ECL) Up 1.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Ecolab (ECL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.